Health
Hard choices emerge as link between AstraZeneca vaccine and rare clotting disorder becomes clearer – Science Magazine
Some scientists suggest halving the dose might reduce risks and help protect more people from COVID-19
By Kai Kupferschmidt, Gretchen VogelApr. 11, 2021 , 7:15 AM
Sciences COVID-19 reporting is supported by the Heising-Simons Foundation.
What was a worrisome suspicion four weeks ago is now widely accepted: The AstraZeneca COVID-19 vaccine can, in very rare cases, cause a disorder characterized by dangerous blood clots and low platelet counts. In Europe, at least 222 suspected cases have been reported among 34 million who have received their first dose of the vaccine. More than 30 have died.
Causality…
-
Noosa News23 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General19 hours ago‘Potential’ hacker contacts Qantas over data breach
-
General24 hours agoReflections from a broken Europe
-
Business10 hours agoFord CEO makes stunning prediction about artificial intelligence